Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
( 7.2 ) 7.1Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin When initiating MOUNJARO, consider reducing the dose of concomitantly administered insulin secretagogues (e.g., sulfonylureas) or insulin to reduce the risk of hypoglycemia [see Warnings and Precautions ( 5.3 )]
Just pure H2O sterilized through filtration or heat
Monthly weight loss of 5 to 10 pounds is common during this active loss phase
Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications
So, she got an unapproved alternative from a local med spa that claims to have the same active ingredient
Possible Side Effects & Cautions Like any medication, GLP-1s can cause side effectsmost commonly nausea, digestive changes, or mild fatigue
